logo-loader

Avivagen commercializing its OxC-beta livestock product around the world

Published: 11:07 19 Jul 2019 EDT

Avivagen Inc (TSXV:VIV) CEO Kym Anthony tells Proactive Investors the Canadian life sciences company has developed and begun commercializing its OxC-beta Livestock product that promotes immune functions in livestock in the the Philippines, Taiwan, New Zealand and Thailand.

Anthony says the product, which has been shown to be effective in replacing the antibiotics added to livestock feeds, will soon be entering the US market.

Novo Resources sees substantial upside potential at Nunyerry

Novo Resources Corp (TSX:NVO, OTCQX:NSRPF, ASX:NVO) co-chair and acting CEO Mike Spreadborough joins Jonathan Jackson in the Proactive studio to discuss promising gold outcomes from recent reanalysis of drill intercepts in a 2023 program at Nunyerry North in Western Australia. Using advanced...

10 hours, 36 minutes ago